Matthias Mann Receives Louis-Jeantet Prize for Medicine - Award for new methods to analyze proteins

Every cell has a vast number of proteins at its command which are involved in practically all biological processes. Every protein undertakes specified tasks and they all need to work together harmoniously. Matthias Mann, director at the Max Planck Institute of Biochemistry in Martinsried near Munich, Germany, is to receive the Louis-Jeantet Prize for Medicine 2012 for his work on the development of mass spectrometric procedures for protein analysis. The award comes with 700,000 CHF prize money (about 540,000 Euros) and will be presented on April 19, 2012 in Geneva, Switzerland.

Matthias Mann pioneered the use of mass spectrometry for the extremely precise study of proteins, their modifications and their interactions. He has thus contributed to the emergence of a new field of research, namely proteomics. His work has significant therapeutic implications, for instance it permits the quantitative analysis of cancerous tumours that could improve the diagnosis and treatment of these diseases. “I want to use the prize money to continue to apply proteomics to high precision analysis of cancerous tumours, with the aim to improve patient diagnosis and choice of treatment” says Matthias Mann.

Contact
Prof. Dr. Matthias Mann
Proteomics and Signal Transduction
Max Planck Institute of Biochemistry
Am Klopferspitz 18
82152 Martinsried
E-Mail: mmann[a]biochem.mpg.de
www.biochem.mpg.de/mann

Anja Konschak
Public Relations
Max Planck Institute of Biochemistry
Am Klopferspitz 18
82152 Martinsried
Phone: +49 (0) 89 8578-2824
E-Mail: konschak[a]biochem.mpg.de
www.biochem.mpg.de